James Lee

James is a strategic leader with broad industry experience building blockbuster global brands and commercial strategies for drug development. He has served in leadership roles over the last 23 years at Novo Nordisk A/S, Paladin Labs Inc., and Zealand Pharma A/S, where he has successfully launched multiple products in specialty, primary care, and rare disease markets.

He holds an MBA in Strategy and BSc in Cell Biology from Queen’s University and is certified as a CPA.